COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration

Luuk B Hilbrands,Raphaël Duivenvoorden,Priya Vart,Casper F M Franssen,Marc H Hemmelder,Kitty J Jager,Lyanne M Kieneker,Marlies Noordzij,Michelle J Pena,Hanne de Vries,David Arroyo,Adrian Covic,Marta Crespo,Eric Goffin,Mahmud Islam,Ziad A Massy,Nuria Montero,João P Oliveira,Ana Roca Muñoz,J Emilio Sanchez,Sivakumar Sridharan,Rebecca Winzeler,Ron T Gansevoort,Jeroen B van der Net,Marie Essig,Peggy W G du Buf-Vereijken,Betty van Ginneken,Nanda Maas,Liffert Vogt,Birgit C van Jaarsveld,Frederike J Bemelman,Farah Klingenberg-Salahova,Frederiek Heenan-Vos,Marc G Vervloet,Azam Nurmohamed,Daniel Abramowicz,Sabine Verhofstede,Omar Maoujoud,Jana Fialova,Edoardo Melilli,Alex Favà,Josep M Cruzado,Joy Lips,Maaike Hengst,Ryszard Gellert,Andrzej Rydzewski,Daniela G Alferes,Ivan Rychlik,Elena V Zakharova,Patrice Max Ambuehl,Fanny Lepeytre,Clémentine Rabaté,Guy Rostoker,Sofia Marques,Tijana Azasevac,Dajana Katicic,Marc ten Dam,Thilo Krüger,Susan J J Logtenberg,Lutz Fricke,A L van Zanen,Jeroen J P Slebe,Delphine Kemlin,Jacqueline van de Wetering,Jaromir Eiselt,Lukas Kielberger,Hala S El-Wakil,Samar Abd ElHafeez,Christina Canal,Carme Facundo,Ana M Ramos,Alicja Debska-Slizien,Nicoline M H Veldhuizen,Stylianos Panagoutsos,Irina Matceac,Ionut Nistor,Monica Cordos,J H M Groeneveld,Marjolijn van Buren,Fritz Diekmann,Ana C Ferreira,Augusto Cesar S Santos,Carlos Arias-Cabrales,Laura Llinàs-Mallol,Anna Buxeda,Carla Burballa Tàrrega,Dolores Redondo-Pachon,Maria Dolores Arenas Jimenez,Julia M Hofstra,Antonio Franco,María L Rodríguez-Ferrero,Sagrario Balda Manzanos,Gabriel de Arriba,R Haridian Sosa Barrios,Karlijn Bartelet,Erol Demir,Daan A M J Hollander,Angele Kerckhoffs,Stefan Büttner,Aiko P.J de Vries,Soufian Meziyerh,Danny van der Helm,Marlies Reinders,Hanneke Bouwsma,Kristina Petruliene,Sharon Maloney,Iris Verberk,Marina Di Luca,Serhan Z Tuğlular,Charles Beerenhout,Peter T Luik,Julia Kerschbaum,Martin Tiefenthaler,Bruno Watschinger,Aaltje Y Adema,Vadim A Stepanov,Alexey B Zulkarnaev,Kultigin Turkmen,Bonucchi Decenzio,Anselm Fliedner,Hitoshi Miyasato,Anders Åsberg,Geir Mjoen,Stefano Pini,Consuelo de Biase,Anne Els van de Logt,Rutger Maas,Olga Lebedeva,Veronica Lopez,Louis J M Reichert,Jacobien Verhave,Denis Titov,Ekaterina V Parshina,Liesbeth E A van Gils-Verrij,Charlotte J R de Bruin,John C Harty,Marleen Meurs,Marek Myslak,Yuri Battaglia,Paolo Lentini,Edwin den Deurwaarder,Hormat Rahimzadeh,Marcel Schouten,Carlos J Cabezas-Reina,Anabel Diaz-Mareque,Armando Coca,Björn K I Meijers,Maarten Naesens,Dirk Kuypers,Bruno Desschans,Annelies Tonnerlier,Karl M Wissing,Ivana Dedinska,Giuseppina Pessolano,Frank M van der Sande,Maarten H L Christiaans,Ilaria Gandolfini,Umberto Maggiore,Nada Kanaan,Laura Labriola,Arnaud Devresse,Shafi Malik,Stefan P Berger,Esther Meijer,Jan Stephan F Sanders,Jadranka Buturović Ponikvar,Alferso C Abrahams,Femke M Molenaar,Arjan D van Zuilen,S C A Meijvis,Helma Dolmans,Luca Zanoli,Carmelita Marcantoni,Pasquale Esposito,Jean-Marie Krzesinski,Jean Damacène Barahira,Maurizio Gallieni,Paloma Leticia Martin-Moreno,Gabriele Guglielmetti,Gabriella Guzzo,Antinus J Luik,Willi H M van Kuijk,Lonneke W H Stikkelbroeck,Marc M H Hermans,Laurynas Rimsevicius,Marco Righetti,Nicole Heitink-ter Braak,

DOI: https://doi.org/10.1093/ndt/gfaa261

IF: 7.1857

2020-10-28

Nephrology Dialysis Transplantation

Abstract:Abstract Background. Patients on kidney replacement therapy comprise a vulnerable population and may be at increased risk of death from coronavirus disease 2019 (COVID-19). Currently, only limited data are available on outcomes in this patient population. Methods. We set up the ERACODA (European Renal Association COVID-19 Database) database, which is specifically designed to prospectively collect detailed data on kidney transplant and dialysis patients with COVID-19. For this analysis, patients were included who presented between 1 February and 1 May 2020 and had complete information available on the primary outcome parameter, 28-day mortality. Results. Of the 1073 patients enrolled, 305 (28%) were kidney transplant and 768 (72%) dialysis patients with a mean age of 60 ± 13 and 67 ± 14 years, respectively. The 28-day probability of death was 21.3% [95% confidence interval (95% CI) 14.3–30.2%] in kidney transplant and 25.0% (95% CI 20.2–30.0%) in dialysis patients. Mortality was primarily associated with advanced age in kidney transplant patients, and with age and frailty in dialysis patients. After adjusting for sex, age and frailty, in-hospital mortality did not significantly differ between transplant and dialysis patients [hazard ratio (HR) 0.81, 95% CI 0.59–1.10, P = 0.18]. In the subset of dialysis patients who were a candidate for transplantation (n = 148), 8 patients died within 28 days, as compared with 7 deaths in 23 patients who underwent a kidney transplantation <1 year before presentation (HR adjusted for sex, age and frailty 0.20, 95% CI 0.07–0.56, P < 0.01). Conclusions. The 28-day case-fatality rate is high in patients on kidney replacement therapy with COVID-19 and is primarily driven by the risk factors age and frailty. Furthermore, in the first year after kidney transplantation, patients may be at increased risk of COVID-19-related mortality as compared with dialysis patients on the waiting list for transplantation. This information is important in guiding clinical decision-making, and for informing the public and healthcare authorities on the COVID-19-related mortality risk in kidney transplant and dialysis patients.

urology & nephrology,transplantation